Philip Bejon

PhD position (Oxford, UK) An exciting opportunity to study the strain dynamics of E. coli across a unique cohort spanning health to disease. with @samlipworth.bsky.social at @modmedmicro.bsky.social More details: http://iddjobs.org/jobs/2600

Come and work with me — postdoc position advertised! You’ll work as part of a team developing new inhibitors to Klebsiella by carrying out computer simulations to work out which lead/target combinations are less likely to evolve resistance @modmedmicro.bsky.social fowlerlab.org/2026/10/21/a...

Since 2016, KWTRP has used radio to connect researchers and communities. During our two-day Open Day, our #JukwaaLaUtafiti radio programme listeners met researchers, toured laboratories and explored the science behind the conversations they hear on air. #KWTRP #CommunityEngagement

📢 PhD opportunity in Edinburgh: Soil carbon change and fungal-bacterial mechanisms in tree planted upland ecosystems. Funded by NERC E5 DTP for September 2027 start. Apply before Dec 2nd. Please share. e5-dtp.ed.ac.uk/project?item...

I am looking for prospective DPhil (PhD) students interested in using computational methods to understand and predict antibiotic resistance. bit.ly/3WesMmh All applicants will be considered for an NDM Prize Studentship. Deadline is Tuesday 1 December 2026.

We published 'negative' research findings! Can MALDI-TOF accurately predict whole genome sequencing-based transmission? Nope. 🥲 We hoped it could (faster, cheaper), but alas, it does not work well! www.cambridge.org/core/journal...

Tiny microbes, big questions and plenty of curious minds at New Scientist Live! We had a brilliant time this weekend bringing our research to life🔬 Curious about what we got up to? Check out our blog post to see Droplet Detectives and Sinks Under Siege activities🦠 ➡️ bashthebug.net/2026/10/13/d...

Researchers @oxprimarycare.bsky.social show that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes oxfordbrc.nihr.ac.uk/wearable-che... #HospitalAtHome @medsci.ox.ac.uk @ouhospitals.bsky.social

This study was unethical when it was announced last year and it remains unethical today. The birth dose of the hepatitis b vaccine prevents perinatal acquisition of the infection. You cannot randomize a group of newborns to not receive it while giving it to others. www.linkedin.com/safety/go/?u...

Fantastic to have been selected for this, we found the reviews constructive and help us on the next version. @philipwfowler.bsky.social @nickdsandy.bsky.social @melodyjp101.bsky.social @modmedmicro.bsky.social @bashthebug.net

We're offering a great DPhil opportunity to look at comparing E. coli strain dynamics in gut in health and disease with ultimate aim of developing novel therapeutics. Opportunity to learn wet and dry lab skills including long-read metagenomics, biostastical + ex-vivo modelling. Happy to chat pls RT!

Infusoria BioArt exhibition exploring microbiology opens at the John Radcliffe Hospital! 📅 26 September – 6 November 2026 📍 Artlink Corridor Gallery, John Radcliffe Hospital, Oxford #ArtAndScience #Microbiology #AntimicrobialResistance #InfectionPrevention #PublicEngagement

Great new work from @dotnagy.bsky.social who has developed EpiSENTRY which performs sample size calculations for public health WGS surviellance studies. She applies to data from the NEKSUS study to estimate how much sequencing is enough for GNBSI surviellance in England. @modmedmicro.bsky.social

In a randomized trial involving adults who received local antibiotics during surgery for orthopedic infection, a short duration of systemic antibiotics was noninferior to a long duration regarding treatment failure at 12 months. Full SOLARIO trial results: https://nej.md/4dgrqwY

Less is more, ortho-ID edition Another game changer in ortho ID from the group that brought you OVIVA Pts with ortho infections who underwent curative surgery (no DAIR) with local implantation of abx were randomized to <=7d vs >=4w ABx No Dif in 12 mo relapse www.nejm.org/doi/full/10.... #IDSky

Cutaneous leishmaniasis is a major problem in Ethiopia & often requires admission for systemic therapy. Liquid nitrogen cryotherapy is an option but also has significant logistic barriers. We evaluated leveraging CO2 cryotherapy deployed for cervical cancer to decenteralise treatment for CL.

Vapes can bring their own problems, but hard to deny the importance of quitting tobacco, the difficulty of quitting, and that they seem to help.

Microbiology is coming out of the lab! Infusoria, a new exhibition by MMM Artist-in-Residence Anna Dumitriu, runs in the JR Hospital from 26 Sept–6 Nov 2026. New works inspired by Oxford research explore hospital sinks, wastewater, water microbiomes and antimicrobial resistance.

Congratulations to our Executive Director, Prof. Edwine Barasa, on his appointment to the renewed @who.int Science Council, joining 20 leading scientists globally. The Council will advise on emerging technologies,breakthroughs & high-priority health issues shaping global health. 🔗: shorturl.at/hQybK

Honoured to be appointed to the WHO Science Council, joining 20 leading scientists from around the world to help shape the future of science, research and innovation for global health. Excited about the work ahead. @kemriwellcome.bsky.social www.who.int/news/item/27...

An outbreak of Mpox is unfolding in Guinea Bissau. Madagascar is also experiencing its first ever outbreak. I would argue that Mpox never left. We have not made the necessary investments in global surveillance and targeted immunization. www.theguardian.com/global-devel...

Our new review is out! We examine the JAK/STAT pathway as a therapeutic target in chronic viral infections, including HIV, hepatitis viruses, SARS-CoV-2 & herpesviruses and the balance between reducing harmful inflammation while preserving antiviral immunity. www.frontiersin.org/journals/imm...

NEWS: 100th patient enrolled in PARTNERS trial to identify the first effective treatments for Bundibugyo ebolavirus disease @psioxford.bsky.social 

This sort of work is what public health should be , patient, collaborative, consistent , over a long enough period of time to really see what’s happening ( and a fantastic drop in childhood deaths to boot)

Great news!! This drop in hospitalisations and deaths in children due to malaria really need to be more widely appreciated!

This is truly great work. Thanks for sharing and congratulations to the team.

Great article and an important message - there's a lot of emphasis on the next hot new malaria intervention, but always important to remember that the fundamentals done really well can have a huge and sustained impact.

Investing in people, creating lasting impact #EDCTP-supported researcher Prof. Abdoulaye Djimdé has been featured in Nature for his contribution to advancing the fight against malaria and strengthening African-led research capacity. 🔗 Read the article: www.nature.com/articles/d44...

🎓Fully funded PhD opportunity! 🔬Ready to make an impact in child health research? Apply for the PhD studentship under the RECOVER study and help improve care for children with severe acute malnutrition. 🔗Apply here👉: shorturl.at/RqNiS 🗓️Deadline : July 3, 2026

Come work @lshtm.bsky.social modelling STIs in UK & evaluation of new interventions. 3yr research fellow modelling post - feel free to get in touch to discuss. Current closing date 30th June @rozeggo.bsky.social @adamjkucharski.bsky.social @grahammedley.bsky.social @drlouisedyson.bsky.social

"[...] as of May 27, 2026, approximately 280–2520 cases of Bundibugyo virus disease might have occurred in [DRC] (estimate range 306–2521 with the back-calculation model and 282–1345 with the geographical spread model); however, there is considerable uncertainty around these estimates."

Updated modelling of the current size of the Ebola outbreak by Imperial and collaborators. Ruth McCabe and co-authors did an incredible job at integrating continuously changing case data 👇

🚨Vaccinology webinar alert!🚨 🧪Curious about how vaccines are developed and standardized? Join our next webinar session with Dr. Selorm Avumegah, @cepi.net, and learn how standards ensure the quality, safety, and effectiveness of vaccines. 🗓️June 24th, 2026 🕑2:00 PM – 3:30 PM EAT 🔗: shorturl.at/4zUWK

🫀How can Africa tackle the growing burden of hypertension? 📚Our latest research highlights why combining proven interventions with locally generated evidence is key to developing solutions that work for African populations. 🔗Read more here 👉: shorturl.at/7FAf4

NIHR webinar on BashTheBug on YouTube BashTheBug was originally a large international citizen science project that invited anyone to help us classify how well different samples of M. tuberculosis grew in the presence of a range of antibiotics. It ran from 2017 to 2021 and in that time 46,427…

NEW: An Oxford-developed vaccine candidate targeting the Bundibugyo strain of Ebola has received backing from CEPI, accelerating efforts to respond to the epidemic in the Democratic Republic of the Congo and Uganda. More info ➡️ https://bit.ly/4uif4KI

Thanks to the team for all their hardwork preparing and delivering the activities, especially in this heatwave! 🌞🌞🌞